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Introduction: We describe a case of diffuse nesidioblastosis in an adult patient who presented with exclusively
fasting symptoms and a focal pancreatic 111In-pentetreotide uptake mimicking an insulinoma.
Case presentation: A 23-year-old Caucasian man had severe daily fasting hypoglycemia with glucose levels below
2mmol/L. Besides rare neuroglycopenic symptoms (confusion, sleepiness), he was largely asymptomatic. His
investigations revealed low venous plasma glucose levels, high insulin and C-peptide levels and a 72-hour fast test
that were all highly suggestive for an insulinoma. Abdominal computed tomography and magnetic resonance imaging
did not reveal any lesions. The sole imagery that was compatible with an insulinoma was a 111In-somatostatin receptor
scintigraphy that showed a faint but definite focal tracer between the head and the body of the pancreas. However,
this lesion could not be confirmed by endoscopic ultrasonography of the pancreas. Following duodenopancreatectomy,
the histological findings were consistent with diffuse nesidioblastosis. Postoperatively, the patient continued to present
with fasting hypoglycemia and was successfully treated with diazoxide.
Conclusion: In the absence of gastrointestinal surgery, nesidioblastosis is very rare in adults. In addition,
nesidioblastosis is usually characterized by post-prandial hypoglycemia, whereas this patient presented with fasting
hypoglycemia. This case also illustrates the risk for a false positive result of 111In-pentetreotide scintigraphy in the case
of nesidioblastosis. Selective arterial calcium stimulation and venous sampling is the most reliable procedure for the
positive diagnosis of insulinoma or nesidioblastosis and should be used to confirm any suspicion based on imaging
modalities.
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Whereas nesidioblastosis is the primary cause of persistent
hyperinsulinemic hypoglycemia in infants, noninsulinoma
pancreatogenous hypoglycemia syndrome (NIPHS) is very
infrequent in adults [1-3]. Nesidioblastosis is the histo-
logical equivalent of noninsulinoma pancreatogenous
hypoglycemia syndrome and refers to an increase in the
size and number of pancreatic beta cells islets with focal
or diffuse hypertrophy and hyperfunction [4]. Nesidioblas-
tosis was first described by Laidlaw in 1938 [5]. The first
adult case was reported in 1975 [6]. Since then, fewer than
100 cases have been reported, all of which occurred in the
absence of gastrointestinal surgery [7-12].* Correspondence: Chiara.Ferrario@chuv.ch
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reproduction in any medium, provided the orThe confirmative diagnosis of NIPHS remains very
challenging despite the improvement of both morpho-
logical and functional imaging techniques [13]. In most
cases, the diagnosis is made postoperatively and is based
on histological findings [14].
Clinically, it is often difficult to distinguish NIPHS from
insulinoma although some authors suggest that post-
prandial hypoglycemia could be indicative for NIPHS.
NIPHS is the cause of endogenous hyperinsulinemia in
less than 5% of the cases [2,3] making this diagnosis un-
likely in patients presenting with hypoglycemic symptoms.
We describe an unusual case of nesidioblastosis with
fasting hypoglycemia and 111In-pentetreotide focal up-
take in the pancreas, mimicking an insulinoma.
Case presentation
A hitherto healthy 23-year-old Caucasian male student
reported a history of several intermittent episodes ofl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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episodes recurred every 2 months. During the episodes,
he was conscious, but felt sleepy, his vision was blurred
and he was unable to talk. In addition, he suffered one
episode of concomitant jaw paralysis. These episodes
happened most frequently upon awakening, but some-
times also late in the afternoon. The family had noticed
that his symptoms improved continuously within 30
minutes of having eaten honey, sugar or fruits. Every
episode was usually followed by headaches. He also
mentioned a weight gain of 6kg over the past year. His
physical examination was normal and a magnetic reson-
ance imaging (MRI) and electroencephalogram with
sleep deprivation failed to demonstrate any abnormality.
However, never was the patient evaluated while symp-
tomatic. He was referred to our endocrinology out-
patient clinic to exclude a metabolic disorder. He had no
family history of any metabolic or endocrine disorders.
In the meantime, his general practitioner taught the
patient to self-monitor his capillary blood glucose levels.
While completely asymptomatic, his fasting glucose
levels ranged between 2.3mmol/L and 3.0mmol/L. None
of the blood glucose measures was done during an episode
of absence.
Laboratory findings on two different occasions re-
vealed low venous fasting plasma glucose concentra-
tions (2.6mmol/L and 1.6mmol/L) with high insulin
(15.5mU/L and 55.3mU/L) and C-peptide (0.762nmol/L
and 0.53nmol/L) levels. A 72-hour fasting test had to be
stopped after 18 hours because of a glucose level ofFigure 1 Somatostatin receptor scintigraphy (OctreoScanW) of the pa
performed 3 hours after injection of 200MBq 111In-pentetreotide and
body of the pancreas. MIP 3D; Maximum intensity projection, three dime1.8mmol/L and a mini-mental state score (MMSE) of 24
out of 30. After an intravenous injection of 1mg of gluca-
gon, the glucose level increased to 4.7mmol/L and the
MMSE to 29 out of 30. A plasma sulfonylureas screen
test at the beginning and at the end of the fasting study
was negative. Anti-insulin antibodies were negative. In-
sulin and C-peptide levels increased during the fasting
test. These results confirmed our clinical suspicion of an
insulinoma.
An abdominal computed tomography (CT) and MRI
did not reveal any lesions. A subsequent somatostatin
receptor scintigraphy (SRS) performed 4 hours and 24
hours after injection of 190MBq 111In-pentetreotide
(OctreoScanW) showed a faint but definite, albeit
discrete, focal abnormality at the junction between the
head and body of the pancreas, compatible with an insu-
linoma (Figure 1). Nevertheless, endoscopic ultrasound
of the pancreas failed to confirm this finding. We
decided not to perform selective intra-arterial calcium
stimulation with hepatic venous sampling at this stage
because we relied on the results of the SRS. We initially
planned to complete the investigations by performing a
glucagon-like peptide-1 (GLP-1) receptor scintigraphy to
confirm the lesion found only on SRS. The patient,
nonetheless, refused this supplementary imaging proced-
ure. After a multidisciplinary discussion, a 111In-pente-
treotide radio-guided surgery was performed. The day
before surgery, the patient received 200MBq of 111In-
pentetreotide and single-photon emission computed
tomography (SPECT) CT, which confirmed the focaltient: single-photon emission computed tomography was
showed a focal uptake at the junction between the head and the
nsional.
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pancreas described above. During surgery, the nuclear
gamma probe detected the increased uptake that was
suspected to be the lesion within the head and the body
of the pancreas, but intraoperative ultrasound failed to
detect any morphological abnormality. Biopsies were
undertaken in the area of this maximal signal intensity
detected by the gamma probe. However, the frozen sec-
tions were not conclusive for an insulinoma. Metallic
clips were put around the biopsy site and the abdomen
was closed. Another SRS was performed 2 weeks after
this first intervention and confirmed that the uptake was
located between the surgical clips, exactly at the same
location as it had been seen on the first SPECTCT. As
the tumor was located deeper in the head of the pan-
creas, a pylorus preserving duodenopancreatectomy was
performed after having obtained the patient’s consent.
Macroscopic examination of the resection specimen
identified no tumor. Microscopically, the lobular archi-
tecture of the exocrine pancreas was preserved and no
ductuloinsular complexes were observed in any speci-
mens. Some of the islets were enlarged and varied in
size; some measuring 0.2cm and randomly scattered
throughout the pancreatic parenchyma. The outlines of
the islets were more irregular than normal (Figure 2). A
consistent finding in all specimens was the presence of
multiple enlarged islet cells showing increased nuclear
size with prominent nucleoli and clear cytoplasm
(Figure 3). There was no mitotic activity. The enlarged
and irregular islets were highlighted with immunohisto-
chemical staining by using antibodies against chromo-
granin and synaptophysin (Figure 4). Approximately half
of all cells within the pancreatic islets were stained withFigure 2 Enlarged pancreatic islet with irregular outline (×4).insulin (Figure 5). By contrast, glucagon and somato-
statin cells did not have any cytologic abnormalities.
Insulin-positive cells were also scattered throughout the
parenchyma. These features, combined with the clinical
and radiological findings, are consistent with diffuse
nesidioblastosis.
Noting that multiple endocrine neoplasia mutations
were described in conjunction with nesidioblastosis, a
menin gene mutation with polymerase chain reaction
enzymatic amplification was performed and was found
to be negative. Calcium, prolactin and insulin-like
growth factor 1 levels were within normal values.
Postoperative recovery was complicated by a wound
infection. Following surgery, the hypoglycemic episodes
continued and a diffuse nesidioblastosis of the pancreatic
distal body and tail was suspected. The patient’s diet was
adapted to provide regular intake of carbohydrates, espe-
cially early in the morning, but the patient’s symptoms
persisted. To avoid further pancreatic resection in such
a young patient, a verapamil treatment was initiated
(40mg twice daily, increasing up to 80mg three times
daily, over 1 week). The patient, however, experienced
severe headaches and palpitation after 3 weeks and
stopped the medication. Diazoxide was then introduced;
initially 100mg twice daily, increasing to 100mg three
times a day, which resulted in a normalization of his glu-
cose level with peaks of up to 7.2mmol/L. A 72-hour
subcutaneous glucose monitoring testing, undertaken
through a glucosensor (CGMS SensorW), revealed nor-
mal glycaemia levels.
Four months after surgery, the patient experienced ab-
dominal pain, more frequent stools (three times a day)
and weight loss (1kg/week). Stool examination showed
Figure 3 Pancreatic beta cells showing increased nuclear size and prominence of nucleoli (×40).
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7g per 24 hours). Therefore, an enzyme substitution was
initiated and dietary advice provided in order to treat the
postoperative malabsorption.
Discussion
Based on the clinical presentation and the biological
findings, we were quite confident that the patient had
an insulinoma localized either in the head of the pancreas
or in the duodenum. The endogenous hyperinsulinemic
hypoglycemia was confirmed and one localization proced-
ure, the SRS, was positive. Interestingly, a positive SRS hasFigure 4 Immunostaining of chromogranin and synaptophysin highlibeen described in three other reports of nesidioblastosis
as a localized focal uptake [3,11]. SRS is known to have a
low sensitivity for insulinoma, being positive in only 50%
of cases, and false positive results of SRS in NIPHS have
been reported [13]. Nesidioblastosis is a challenge and
diagnosis is rarely made before surgery [15]. The histo-
pathological diagnosis of nesidioblastosis has primarily
been histological, as in this case, but the criteria employed
to make the diagnosis in adults have, until recently, been
somewhat unclear. Recently proposed criteria are: (1) ex-
clusion of an insulinoma by macroscopic, microscopic and
immunohistochemical examination; (2) multiple beta cellsghted the enlarged and irregular islets (×10).
Figure 5 Approximately half of all cells within the pancreatic islets were stained with insulin (×20).
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dant clear cytoplasm; (3) islets with normal spatial distri-
bution of the various cell types; and (4) no proliferative
activity of endocrine cells [15].
Retrospectively, the scintigraphic suspicion should
have been further confirmed before surgery. Selective ar-
terial calcium stimulation and venous sampling is a use-
ful tool for the diagnosis and treatment decision of
NIPHS, especially with respect to the extent of pancrea-
tectomy. The sensitivity of this technique is reported to
be nearly 100% for the diagnosis of insulinomas and
should be able to discriminate the focal insulinoma from
the more diffuse pattern of nesidioblastosis [10,13,15]. It
is possible that the selective arterial calcium stimulation
would have shown increased insulin levels following
stimulation from the gastroduodenal artery and in a
lower proportion from the superior mesenteric and from
the splenic arteries as well. New diagnostic options such
as dihydroxyphenylalanine (DOPA)-positron emission
tomography and, the more recent, GLP-1 scintigraphy,
could have been useful to confirm the localization of the
suspected insulinoma. However, their value in discrimin-
ating the focal insulinoma from the diffuse nesidioblas-
tosis has not yet been demonstrated. Before proceeding
to the surgery, we proposed to the patient to conduct
additional diagnostic examinations to confirm the scinti-
graphic findings, but he refused for personal reasons. In
any case, the outside nuclear department performing the
GLP-1 scintigraphy felt that this test would not provide
any additional information.
Persistent hyperinsulinemic hypoglycemia of infancy
(PHHI) can occur as a result of mutations in the subunits
that form the adenosine-5'-triphosphate (ATP)-sensitivepotassium channel (K+ATP) in pancreatic beta cells,
which play a major role in modulating insulin secretion
from the beta cells. Mutations have been shown in the
genes for these subunits, namely for the plasma mem-
brane sulfonylurea receptor (SUR1), ABCC8, and its asso-
ciated inwardly rectifying potassium channel (KIR6.2)
KCNJ11. These genetic defects are known to be relevant
in the development of PHHI and at least some of them
are very likely to be prevalent also in adults with the dis-
ease. Although the mode of inheritance is autosomal re-
cessive in some and dominant in others, spontaneous
mutations may of course be of importance too. We ana-
lyzed the family history of the patient and found no spe-
cific features in other family members (e.g. gestational
diabetes in females, unexplained diabetes in non-obese
individuals etc.). The favorable response to diazoxide may
even give a hint towards which mechanisms may be
involved. Specifically, diazoxide which acts on K+ATP
channels seems to need intact ABCC8 to be able to show
its effects. Because many of the potential mutations in the
genes responsible are well known, we could have per-
formed genetic analysis in order to clarify the situation, es-
pecially because the patient was young and could have
children in the future. To this date, the patient did not
wish to perform any other test, but a possible genetic ana-
lysis should be discussed with him in the future.
In cases of nesidioblastosis, the extent of surgery is
controversial. Ideally, surgery should not be performed
without a preoperative localization technique. If laparos-
copy or laparotomy cannot detect an insulinoma, then
Rostambeigi and Thompson recommend that surgery
should stop so as to avoid performing a blind distal pan-
creatic resection, and investigations should be completed
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[16]. Recommendations are based on small series, case
reports and experience in children with nesidioblastosis.
The preferred option is an extended left-sided pancreatic
resection or a Whipple’s procedure with 70% to 90%
pancreas resection [10,15], followed by partial resection
(<60%) and subtotal to total pancreatectomy (>90%)
[13]. Conservative therapy is sometimes suggested. Diaz-
oxide, octreotide and verapamil could be effective and
safe alternative conservative therapies when surgery has
failed or is considered to be too risky [8,10]. Patients’ in-
formation should include the necessity for multiple diag-
nostic procedures and the postoperative risks for
pancreatic exocrine insufficiency and diabetes. In the
present case, total pancreatectomy was not proposed
due to the young age and the consecutive morbidity of
such a procedure [7,13].
Conclusion
Nesidioblastosis is very rare in adults in the absence of
previous gastrointestinal surgery. This case illustrates
the difficulties and limitations of diagnostic imaging pro-
cedures and the risk for a false positive result of 111In-
pentetreotide scintigraphy in case of nesidioblastosis. Se-
lective arterial calcium stimulation and venous sampling
is the most reliable procedure for the positive diagnosis
of insulinoma or nesidioblastosis and should be used to
confirm any suspicion based on imaging modalities.
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